TPA-IM

TPA-IM is an Aβ40-binding inhibitor with a Ka of 12.7 nM. TPA-IM inhibits amyloid-β fibrillation and disrupts preformed fibrils. TPA-IM inhibits intracellular ROS production, restores mitochondrial membrane potential, attenuates amyloid-β-induced apoptosis (apoptosis), and rescues amyloid-β-induced loss of neuronal viability. TPA-IM self-assembles into spherical nanoaggregates and co-assembles with amyloid-β, redirecting aggregation toward non-fibrillar structures. TPA-IM can be used for research on Alzheimer's disease.

For research use only. We do not sell to patients.

  • Formula: C33H23N3O3
  • Molecular Weight:509.55
  • Storage:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Biological Activity
  • Chemical Information
  • Protocols
  • Purity & Documentation
  • References
  • Help & FAQs
MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00